Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Nutranomics, Inc.
DRAPER, Utah, Oct. 22, 2013 /PRNewswire/ -- Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the Company has appointed Mr. Michael J. Brousseau as its new General Manager. Mr. Brousseau has more than 10 years of international experience in sales, logistics, and management in 12 different countries and a proven track record of success in the development and execution of creative marketing and selling strategies for nutritional supplement companies.
"We are extremely excited to be able to add an executive of Michael Brousseau's caliber to the Nutranomics team. He is the ideal person for this important new position," said Dr. Tracy K. Gibbs, CEO of Nutranomics. "His extensive experience with large nutritional supplement companies will be an invaluable asset as we continue to execute and accelerate our global sales and marketing plans."
Prior to joining Nutranomics, from 2006-2011, Michael was an Area Director with Nature's Sunshine Products, one of the oldest and largest manufacturers of premium encapsulated herbs and a pioneer of the network marketing industry. His responsibilities included the creation and execution of growth strategies across Canada, Russia/CIS, Europe, and the Middle East. During his time with Nature's Sunshine Products, both sales and operating income increased significantly.
From 2004-2006, Michael held various regional and senior operations management positions with Xango LLC, a recognized category creator as the first company to market a premium mangosteen beverage, Xango® Juice, to consumers worldwide. During this time, he served as Regional Operations Manager - Europe & Americas where he managed business operations in US, Canada, Australia, New Zealand, and the UK. As Senior Manager - Europe, Middle East, and Africa, Michael created business plans and developed strategic market action plans for the UK, Germany, Sweden, Norway, Finland, Denmark, and Holland.
From 2001-2004, Mr. Brousseau was a Corporate Regional Manager of Neways International, a $600 million company that sells quality personal care products, cosmetics, and nutritional supplements in 23 different countries. While with Neways, Mr. Brousseau managed approximately $65 million in annual revenue from five of the top six Neways markets and drove top line sales initiatives, operational budgets, and warehouse operations in Canada, Latin America, the UK, Germany, Australia and New Zealand.
Nutranomics is a publicly traded company engaged in research and development of nutritional food products. In 1997, Nutranomics produced and branded its own product line, and began to sell to the retail outlets and to the public. Nutranomics has also produced formulas for hundreds of other companies. Nutranomics' mission is to increase human health and longevity through education and self-awareness. The Company has sales representatives throughout North America and Asia.
For further information regarding Nutranomics, Inc., please contact our investor relations representatives at firstname.lastname@example.org or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include the Company's plan to execute and accelerate its global sales and marketing plans. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
©2012 PR Newswire. All Rights Reserved.